BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 22159586)

  • 1. MAPK pathway activation in pilocytic astrocytoma.
    Jones DT; Gronych J; Lichter P; Witt O; Pfister SM
    Cell Mol Life Sci; 2012 Jun; 69(11):1799-811. PubMed ID: 22159586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.
    Tomić TT; Olausson J; Wilzén A; Sabel M; Truvé K; Sjögren H; Dósa S; Tisell M; Lannering B; Enlund F; Martinsson T; Åman P; Abel F
    PLoS One; 2017; 12(4):e0175638. PubMed ID: 28448514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice.
    Gronych J; Korshunov A; Bageritz J; Milde T; Jugold M; Hambardzumyan D; Remke M; Hartmann C; Witt H; Jones DT; Witt O; Heiland S; Bendszus M; Holland EC; Pfister S; Lichter P
    J Clin Invest; 2011 Apr; 121(4):1344-8. PubMed ID: 21403401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.
    Jones DT; Kocialkowski S; Liu L; Pearson DM; Ichimura K; Collins VP
    Oncogene; 2009 May; 28(20):2119-23. PubMed ID: 19363522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.
    Cin H; Meyer C; Herr R; Janzarik WG; Lambert S; Jones DT; Jacob K; Benner A; Witt H; Remke M; Bender S; Falkenstein F; Van Anh TN; Olbrich H; von Deimling A; Pekrun A; Kulozik AE; Gnekow A; Scheurlen W; Witt O; Omran H; Jabado N; Collins VP; Brummer T; Marschalek R; Lichter P; Korshunov A; Pfister SM
    Acta Neuropathol; 2011 Jun; 121(6):763-74. PubMed ID: 21424530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma.
    Pathak P; Kumar A; Jha P; Purkait S; Faruq M; Suri A; Suri V; Sharma MC; Sarkar C
    Brain Pathol; 2017 Sep; 27(5):580-589. PubMed ID: 27608415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
    Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
    Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.
    Raabe EH; Lim KS; Kim JM; Meeker A; Mao XG; Nikkhah G; Maciaczyk J; Kahlert U; Jain D; Bar E; Cohen KJ; Eberhart CG
    Clin Cancer Res; 2011 Jun; 17(11):3590-9. PubMed ID: 21636552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma.
    Eisenhardt AE; Olbrich H; Röring M; Janzarik W; Anh TN; Cin H; Remke M; Witt H; Korshunov A; Pfister SM; Omran H; Brummer T
    Int J Cancer; 2011 Nov; 129(9):2297-303. PubMed ID: 21190184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system.
    Reis GF; Bloomer MM; Perry A; Phillips JJ; Grenert JP; Karnezis AN; Tihan T
    Mod Pathol; 2013 Oct; 26(10):1279-87. PubMed ID: 23702730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new NFIA:RAF1 fusion activating the MAPK pathway in pilocytic astrocytoma.
    Yde CW; Sehested A; Mateu-Regué À; Østrup O; Scheie D; Nysom K; Nielsen FC; Rossing M
    Cancer Genet; 2016 Oct; 209(10):440-444. PubMed ID: 27810072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel GIT2-BRAF fusion in pilocytic astrocytoma.
    Helgager J; Lidov HG; Mahadevan NR; Kieran MW; Ligon KL; Alexandrescu S
    Diagn Pathol; 2017 Nov; 12(1):82. PubMed ID: 29141672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells.
    Reitman ZJ; Paolella BR; Bergthold G; Pelton K; Becker S; Jones R; Sinai CE; Malkin H; Huang Y; Grimmet L; Herbert ZT; Sun Y; Weatherbee JL; Alberta JA; Daley JF; Rozenblatt-Rosen O; Condurat AL; Qian K; Khadka P; Segal RA; Haas-Kogan D; Filbin MG; Suva ML; Regev A; Stiles CD; Kieran MW; Goumnerova L; Ligon KL; Shalek AK; Bandopadhayay P; Beroukhim R
    Nat Commun; 2019 Aug; 10(1):3731. PubMed ID: 31427603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.
    Jones DT; Hutter B; Jäger N; Korshunov A; Kool M; Warnatz HJ; Zichner T; Lambert SR; Ryzhova M; Quang DA; Fontebasso AM; Stütz AM; Hutter S; Zuckermann M; Sturm D; Gronych J; Lasitschka B; Schmidt S; Seker-Cin H; Witt H; Sultan M; Ralser M; Northcott PA; Hovestadt V; Bender S; Pfaff E; Stark S; Faury D; Schwartzentruber J; Majewski J; Weber UD; Zapatka M; Raeder B; Schlesner M; Worth CL; Bartholomae CC; von Kalle C; Imbusch CD; Radomski S; Lawerenz C; van Sluis P; Koster J; Volckmann R; Versteeg R; Lehrach H; Monoranu C; Winkler B; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; Ebinger M; Schuhmann MU; Cho YJ; Pomeroy SL; von Deimling A; Witt O; Taylor MD; Wolf S; Karajannis MA; Eberhart CG; Scheurlen W; Hasselblatt M; Ligon KL; Kieran MW; Korbel JO; Yaspo ML; Brors B; Felsberg J; Reifenberger G; Collins VP; Jabado N; Eils R; Lichter P; Pfister SM;
    Nat Genet; 2013 Aug; 45(8):927-32. PubMed ID: 23817572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of the MAPK pathway in pilocytic astrocytomas.
    Salles D; Santino SF; Ribeiro DA; Malinverni ACM; Stávale JN
    Pathol Res Pract; 2022 Apr; 232():153821. PubMed ID: 35231859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilomyxoid astrocytomas: a short review.
    Kulac I; Tihan T
    Brain Tumor Pathol; 2019 Apr; 36(2):52-55. PubMed ID: 30945015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.
    Jeuken JW; Wesseling P
    J Pathol; 2010 Dec; 222(4):324-8. PubMed ID: 20976706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior.
    Bannykh SI; Mirocha J; Nuno M; Lopategui J; Kandala G
    Clin Neuropathol; 2014; 33(6):388-98. PubMed ID: 25066317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico analysis identifies a putative cell-of-origin for BRAF fusion-positive cerebellar pilocytic astrocytoma.
    Younes ST; Herrington B
    PLoS One; 2020; 15(11):e0242521. PubMed ID: 33206716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinase in gliosis and pilocytic astrocytoma.
    Takeuchi H; Neishi H; Higashino Y; Kitai R; Kikuta KI; Imamura Y
    Clin Neuropathol; 2018; 37(1):36-41. PubMed ID: 29168690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.